Overview

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

Status:
Completed

Trial end date:
2008-05-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplant may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: This phase II trial is studying how well chemotherapy and peripheral stem cell transplant work in treating patients with multiple myeloma or primary systemic amyloidosis.

Phase:

Phase 2

Details

Lead Sponsor:

Herbert Irving Comprehensive Cancer Center

Collaborator:

National Cancer Institute (NCI)

Treatments:

Busulfan
Cyclophosphamide
Interferon-alpha
Interferons
Melphalan
Sargramostim